Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aetiology and pathogenesis of hidradenitis suppurativa
Kerstin Wolk, Olivier Join‐Lambert, Robert Sabat
British Journal of Dermatology (2020) Vol. 183, Iss. 6, pp. 999-1010
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 112
Hidradenitis suppurativa
Robert Sabat, Afsáneh Alavi, Kerstin Wolk, et al.
The Lancet (2025)
Open Access | Times Cited: 2
Hidradenitis Suppurativa: Where We Are and Where We Are Going
Emanuele Scala, Sara Cacciapuoti, Natalie Garzorz‐Stark, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2094-2094
Open Access | Times Cited: 91
Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions
Kacey L. Sachen, C Greving, Jennifer E. Towne
Cytokine (2022) Vol. 156, pp. 155897-155897
Open Access | Times Cited: 60
Vulvar Lichen Sclerosus from Pathophysiology to Therapeutic Approaches: Evidence and Prospects
Monica Corazza, Natale Schettini, Pierantonia Zedde, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 950-950
Open Access | Times Cited: 55
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
James G. Krueger, John W. Frew, Gregor B. E. Jemec, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 2, pp. 149-162
Open Access | Times Cited: 28
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa
Alexa B. Kimball, Elena Peeva, Seth Forman, et al.
NEJM Evidence (2024) Vol. 3, Iss. 3
Closed Access | Times Cited: 13
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa
Laura Calabrese, Dalma Malvaso, Giulia Coscarella, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 175-175
Open Access | Times Cited: 8
Activity and components of the granulocyte colony‐stimulating factor pathway in hidradenitis suppurativa*
Kerstin Wolk, Theresa-Charlotte Brembach, Deimantė Šimaitė, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 1, pp. 164-176
Open Access | Times Cited: 53
Target molecules for future hidradenitis suppurativa treatment
Christos C. Zouboulis, John W. Frew, Evangelos J. Giamarellos‐Bourboulis, et al.
Experimental Dermatology (2021) Vol. 30, Iss. S1, pp. 8-17
Open Access | Times Cited: 53
Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients
Sylke Schneider‐Burrus, A. Tsaousi, Sebastian Barbus, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 51
Aquaporins Are One of the Critical Factors in the Disruption of the Skin Barrier in Inflammatory Skin Diseases
Paola Maura Tricarico, Donatella Mentino, Aurora De Marco, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4020-4020
Open Access | Times Cited: 37
Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum
Kristina Navrazhina, John W. Frew, David Grand, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 2, pp. 223-233
Open Access | Times Cited: 36
Innate immunity and microbial dysbiosis in hidradenitis suppurativa – vicious cycle of chronic inflammation
Divya Chopra, Rachel A. Arens, Watcharee Amornpairoj, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Transcriptome Meta-Analysis Confirms the Hidradenitis Suppurativa Pathogenic Triad: Upregulated Inflammation, Altered Epithelial Organization, and Dysregulated Metabolic Signaling
Ana Sofia Lima Estevão de Oliveira, Giovanna Bloise, Chiara Moltrasio, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1371-1371
Open Access | Times Cited: 28
Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation
Hakim Ben Abdallah, Sabine Seeler, Anne Bregnhøj, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativa
Rebecca Jepsen, C M Edwards, Akshay Flora, et al.
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 4, pp. 694-702
Closed Access | Times Cited: 19
The epidermal lipid barrier in microbiome–skin interaction
Arnaud Kengmo Tchoupa, Dorothee Kretschmer, Birgit Schittek, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 7, pp. 723-734
Closed Access | Times Cited: 18
S2k-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa (ICD-10-Code: L73.2)
Christos C. Zouboulis, Falk G. Bechara, Klaus Fritz, et al.
Aktuelle Dermatologie (2024) Vol. 50, Iss. 01/02, pp. 30-83
Closed Access | Times Cited: 7
Gram‐negative anaerobes elicit a robust keratinocytes immune response with potential insights into HS pathogenesis
Samuel C. Williams, Sandra Garcet, Hong Hur, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 5
Open Access | Times Cited: 7
Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa
Ester Del Duca, Paola Morelli, Luigi Bennardo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8436-8436
Open Access | Times Cited: 49
Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa
Robert Sabat, Deimantė Šimaitė, Jóhann E. Guðjónsson, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 1015-1026
Closed Access | Times Cited: 27
The impact of hidradenitis suppurativa on professional life
Sylke Schneider‐Burrus, Stefanie Kalus, Björn Fritz, et al.
British Journal of Dermatology (2022) Vol. 188, Iss. 1, pp. 122-130
Closed Access | Times Cited: 22
Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis
Ya‐Chu Tsai, Chen‐Yiu Hung, Tsen‐Fang Tsai
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1351-1351
Open Access | Times Cited: 15
Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators
Róisín Hambly, Niamh Kearney, Rosalind Hughes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6969-6969
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top